NT-proBNP Predicts Complications in Hypertensive Pregnancies

Heart Defects Run in Families, With More Maternal Influence

Viatris Expands Innovative Portfolio in Cardiovascular Diseases with the Company’s First Launch of Inpefa® (Sotagliflozin) for the Treatment of Heart Failure

High Lactate Dehydrogenase Predicts Worse Outcomes in HFrEF

New-look heart failure treatment shows early promise

Vascular surgeon indicted for murder of ex-wife and her husband

Post-TAVR echocardiography helps predict a patient’s long-term risk of SVD

Pivotal trial highlights safety, effectiveness of FDA-approved carotid stent

Abbott’s Navitor TAVR valve linked to positive real-world outcomes

Jan 16 2026 This Week in Cardiology